Market Overview
Jalisco, Mexico โ medical cannabis framework
Guadalajara biotech hub; several COFEPRIS-licensed processors
SADER licensed
On medical cannabis
Personal possession (SCJN)
Production Volume
Medical cannabis manufacturing and hemp cultivation
Hemp Cultivation Area (ha) 2020-2025
Medical Cannabis Sales
Product type breakdown
Medical Product Mix 2025
Medical Product Revenue (MX$M)
Revenue Statistics
Medical revenue trends 2020-2025
Est. Medical Cannabis Revenue (MX$M)
Estimated medical cannabis sales โ COFEPRIS licensed
| Year | Med. Revenue (MX$M) | Hemp Area (ha) | YoY Rev. ฮ | Key Development |
|---|---|---|---|---|
| 2020 | MX$8M | 126ha | โ | Base year |
| 2021 | MX$11M | 184ha | +37.5% | LGS reform full |
| 2022 | MX$14M | 243ha | +27.3% | COFEPRIS regulation |
| 2023 | MX$16M | 302ha | +14.3% | Market growth |
| 2024 | MX$19M | 361ha | +18.8% | Expansion |
| 2025 | MX$22M | 420ha | +15.8% | Current |
Jalisco โ Mexico Cannabis Market 2025
Jalisco participates in Mexico's federally-regulated medical cannabis framework. With an estimated MX$22M in medical revenue and 420ha of licensed hemp, the state reflects broader national trends: strong medical growth, expanding CBD market, and significant potential when adult-use legislation is enacted.
Key Factors
Market drivers in {nm}
๐๏ธ Federal Framework
Mexico's cannabis is regulated federally. Medical cannabis legal since 2021 (LGS reform). SCJN 2019 jurisprudence decriminalised personal possession โค5g. Adult-use market regulation pending Congress.
๐ Market Growth
Jalisco's estimated medical market has grown +18% YoY driven by prescription uptake, CBD product availability, and expanding COFEPRIS licensing.
๐ฑ Hemp Sector
Jalisco has approximately 420 hectares under hemp cultivation licensed by SADER. Industrial hemp (โค1% THC Mexican standard) supplies CBD product manufacturers.
โ๏ธ Adult-Use Limbo
The SCJN's 2019 declaration made prohibition unconstitutional but Congress has not passed adult-use legislation. Citizens may obtain amparos for personal home cultivation.
๐ฐ Tax Structure
16% IVA applies to all medical cannabis sales. No cannabis-specific excise (IEPS) yet. Business expenses are deductible โ unlike US ยง 280E.
๐ฎ Outlook
Congressional action on adult-use legislation could unlock a major market. Illicit-to-legal conversion in Jalisco's agricultural zones represents long-term opportunity.
Timeline
Cannabis legislation milestones in Mexico
Federal reform decriminalises possession of โค5g of cannabis.
LGS amendment allows cannabis for medical and scientific purposes (<1% THC OTC).
Supreme Court (SCJN) declares absolute prohibition unconstitutional; issues binding jurisprudence 2019.
Complete medical cannabis regulatory framework implemented. CDMX passes local Cannabis Law. Jalisco aligns with federal framework.
Full adult-use market law awaits Congressional action. Medical market continues expanding.
โ ๏ธ Data Disclaimer
- All figures are estimates from government agencies, industry associations, and academic research.
- Cannabis markets are rapidly evolving; data reflects estimates as of March 2026.
- Some figures are projections or modelled estimates where official data is unavailable.
- CannBus accepts no liability for decisions made based on information on this page.
๐ References & Sources
- USDA / State Revenue Departments โ Annual Cannabis Tax Reports
- MJBizDaily โ State-by-State Cannabis Market Data 2020โ2025
- BDSA Cannabis Market Intelligence โ Retail Sales Reports
- Health Canada โ Cannabis Market Data Reports
- COFEPRIS / CONASAMES โ Mexico Medical Cannabis Framework
- UNODC โ World Drug Report 2024
- New Frontier Data โ Cannabis Industry Annual Report 2025
- Whitney Economics โ US Cannabis Industry Report 2025
- Statista Cannabis Market โ Global & Regional Data 2024
- CannBus Market Reports ยท www.cannbus.org ยท March 2026
CannBus Market Reports are provided for informational purposes only. Not investment advice.